in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
DSM Acquires German Biotech Firm
9:25 AM MDT | June 2, 2009 | Deepti Ramesh
DSM says it has entered into an agreement to acquire privately held biotechnology company Biopract (Berlin). Financial details of the deal were not disclosed. The acquisition of Biopract will serve as an entry point for DSM into the biogas market, which is growing at 15%-20%/ year, DSM says. Biopract mainly focuses on the commercialization and extension of its enzyme series for the improvement of agricultural and industrial biogas production. “We are convinced that biotechnology will contribute significantly to the sustainable and efficient use of natural...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee